GACM
AGIO icon

Green Arrow Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Green Arrow Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-75,000
Closed -$4.6M – 130
2014
Q3 		$4.6M Buy
75,000
+47,097
+169% +$2.03M 0.39% 65
2014
Q2 		$1.28M Sell
27,903
-52,097
-65% -$2.12M 0.16% 125
2014
Q1 		$3.13M Buy
+80,000
New +$2.68M 0.27% 128

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Green Arrow Capital Management's AGIO Position: Q4 2014 in Review

Green Arrow Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2014, closing a stake of 75,000 shares — an estimated $4.6M sold.

Green Arrow Capital Management first reported a position in AGIO in Q1 2014 and held it in 3 quarters. The position peaked at $4.6M in Q3 2014. 142 funds tracked by Wall St. Rank hold AGIO as of Q4 2014.

  • Green Arrow Capital Management reported no remaining Agios Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 75,000 Agios Pharmaceuticals shares in Q4 2014, an estimated $4.6M.
  • Green Arrow Capital Management first reported a position in Agios Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Green Arrow Capital Management's Agios Pharmaceuticals position peaked at $4.6M in Q3 2014.
  • 142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.